Toll Free: 1-888-928-9744
Published: Mar, 2014 | Pages:
28 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Respiratorius AB - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Respiratorius AB - Product Pipeline Review - 2014', provides an overview of the Respiratorius AB's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Respiratorius AB's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Respiratorius AB including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Respiratorius AB's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Respiratorius AB's pipeline products Reasons to buy - Evaluate Respiratorius AB's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Respiratorius AB in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Respiratorius AB's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Respiratorius AB and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Respiratorius AB - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Respiratorius AB and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Respiratorius AB Snapshot 5 Respiratorius AB Overview 5 Key Information 5 Key Facts 5 Respiratorius AB - Research and Development Overview 6 Key Therapeutic Areas 6 Respiratorius AB - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Respiratorius AB - Pipeline Products Glance 10 Respiratorius AB - Clinical Stage Pipeline Products 10 Phase II Products/Combination Treatment Modalities 10 Respiratorius AB - Early Stage Pipeline Products 11 Preclinical Products/Combination Treatment Modalities 11 Discovery Products/Combination Treatment Modalities 12 Respiratorius AB - Drug Profiles 13 valproate sodium 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 RESP-1000 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 RESP-2000 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 RESP-1100 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 RESP-1200 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 RESP-2100 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 RESP-2200 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Respiratorius AB - Pipeline Analysis 20 Respiratorius AB - Pipeline Products by Target 20 Respiratorius AB - Pipeline Products by Route of Administration 21 Respiratorius AB - Pipeline Products by Molecule Type 22 Respiratorius AB - Pipeline Products by Mechanism of Action 23 Respiratorius AB - Recent Pipeline Updates 24 Respiratorius AB - Dormant Projects 25 Respiratorius AB - Locations And Subsidiaries 26 Head Office 26 Appendix 27 Methodology 27 Coverage 27 Secondary Research 27 Primary Research 27 Expert Panel Validation 27 Contact Us 28 Disclaimer 28
List of Tables Respiratorius AB, Key Information 5 Respiratorius AB, Key Facts 5 Respiratorius AB - Pipeline by Indication, 2014 7 Respiratorius AB - Pipeline by Stage of Development, 2014 8 Respiratorius AB - Monotherapy Products in Pipeline, 2014 9 Respiratorius AB - Phase II, 2014 10 Respiratorius AB - Preclinical, 2014 11 Respiratorius AB - Discovery, 2014 12 Respiratorius AB - Pipeline by Target, 2014 20 Respiratorius AB - Pipeline by Route of Administration, 2014 21 Respiratorius AB - Pipeline by Molecule Type, 2014 22 Respiratorius AB - Pipeline Products by Mechanism of Action, 2014 23 Respiratorius AB - Recent Pipeline Updates, 2014 24 Respiratorius AB - Dormant Developmental Projects,2014 25
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.